losartan has been researched along with Vascular Injuries in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Awata, WMC | 1 |
| Alves, JV | 1 |
| Costa, RM | 1 |
| Bruder-Nascimento, A | 1 |
| Singh, S | 1 |
| Barbosa, GS | 1 |
| Tirapelli, CR | 1 |
| Bruder-Nascimento, T | 1 |
1 other study available for losartan and Vascular Injuries
| Article | Year |
|---|---|
Vascular injury associated with ethanol intake is driven by AT1 receptor and mitochondrial dysfunction.
Topics: Animals; Ethanol; Humans; Hydrogen Peroxide; Losartan; Male; Mice; Mitochondria; Reactive Oxygen Spe | 2023 |